To the editor: The increasing availability of magnetic resonance imaging (MRI) paired with an aging population, of whom many are going to be pacemaker (PM) recipients, will lead to a… Click to show full abstract
To the editor: The increasing availability of magnetic resonance imaging (MRI) paired with an aging population, of whom many are going to be pacemaker (PM) recipients, will lead to a growing number of MRI scans in these patients. Some authors expect 50–70% of patients with a PM to be in need of an MRI scan in their lifetime. The first MRI-conditional transvenous PM was approved by the US Food and Drug Administration (FDA) in 2011, enabling MRI scans in PM patients. In this context, the Micra Transcatheter Pacing System (TPS, Medtronic, Minneapolis, MN) is a novel leadless cardiac PM that is designed to be MRI-conditional for 1.5T and 3.0T scans. Only rare data exist of MRI scans for patients with a TPS system.
               
Click one of the above tabs to view related content.